Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel®

被引:0
|
作者
Laura S. Gold
Kangho Suh
Patricia B. Schepman
Kavitha Damal
Ryan N. Hansen
机构
[1] University of Washington,Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program
[2] University of Washington,Department of Radiology, Pharmaceutical Outcomes Research and Policy Program
[3] Regional Outcomes,Department of Health Services, Pharmaceutical Outcomes Research and Policy Program
[4] Sanofi U.S.,undefined
[5] Santen Incorporated,undefined
[6] University of Washington,undefined
来源
Advances in Therapy | 2016年 / 33卷
关键词
Costs; H.P. Acthar; gel (repository corticotropin injection); Healthcare resource utilization; Intravenous immunoglobulin; Multiple sclerosis; Neurology; Plasmapheresis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1279 / 1292
页数:13
相关论文
共 50 条
  • [21] Impact of relapses on total costs of care for patients with multiple sclerosis
    Akhras, K.
    Cisternas, M.
    Foreman, A.
    Miller, D. H.
    Bennett, R.
    AL-Sabbagh, A.
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 : S121 - S122
  • [22] Follow-up results of myositis patients treated with H. P. Acthar gel
    Saygin, Didem
    Oddis, Chester, V
    Marder, Galina
    Moghadam-Kia, Siamak
    Nandkumar, Preeya
    Neiman, Nicole
    Dzanko, Sedin
    Koontz, Diane
    Aggarwal, Rohit
    RHEUMATOLOGY, 2020, 59 (10) : 2976 - 2981
  • [23] Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants
    Streiff, Michael
    Milentijevic, Dejan
    McCrae, Keith R.
    Laliberte, Francois
    Lejeune, Dominique
    Lefebvre, Patrick
    Schein, Jeff
    Khorana, Alok A.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (11) : 1134 - 1140
  • [24] Healthcare resource utilization (HRU) and costs associated with renal impairment (RI) among treated multiple myeloma (MM) patients
    Medhekar, Rohan
    Gilligan, Adrienne M.
    Kent, Shia T.
    Feng, Chaoling
    Henriques, Caroline
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH CERVICAL DYSTONIA
    Hull, M.
    Anupindi, R.
    He, J.
    Danchenko, N.
    DeKoven, M.
    Bouchard, J.
    VALUE IN HEALTH, 2022, 25 (01) : S106 - S106
  • [26] HEALTHCARE RESOURCE UTILIZATION AND COSTS OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA
    Bhowmik, D.
    Hines, D. M.
    Intorcia, M.
    McGuiness, C. B.
    Wade, R. L.
    VALUE IN HEALTH, 2017, 20 (05) : A103 - A103
  • [27] Healthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazine
    Huang, Huan
    Schmerold, Luke
    Dembek, Carole
    Fan, Qi
    Dieyi, Christopher
    Williams, G. Rhys
    Loebel, Antony
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 352 - 362
  • [28] Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity
    Murage, Mwangi J.
    Anderson, Amanda
    Oliveria, Susan A.
    Casso, Deborah
    Ojeh, Clement K.
    Muram, Talia M.
    Merola, Joseph F.
    Araujo, Andre B.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) : 745 - 754
  • [29] Healthcare resource utilization and costs in patients with multiple myeloma with and without skeletal-related events
    Ailawadhi, Sikander
    Medhekar, Rohan
    Princic, Nicole
    Fowler, Robert
    Tran, Oth
    Bhowmik, Debajyoti
    Panjabi, Sumeet
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) : 1070 - 1079
  • [30] Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment
    Ziemssen, Tjalf
    Prosser, Christine
    Haas, Jennifer Scarlet
    Lee, Andrew
    Braun, Sebastian
    Landsman-Blumberg, Pamela
    Kempel, Angela
    Gleissner, Erika
    Patel, Sarita
    Huang, Ming-Yi
    BMC NEUROLOGY, 2017, 17